Modelling the cost-effectiveness PCSK9 inhibitors vs....

  • Main
  • 2017 / 04
  • Modelling the cost-effectiveness PCSK9 inhibitors vs....

Modelling the cost-effectiveness PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting

Korman, Max, Wisløff, Torbjørn
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
European Heart Journal - Cardiovascular Pharmacotherapy
DOI:
10.1093/ehjcvp/pvx010
Date:
April, 2017
File:
PDF, 1.75 MB
english, 2017
Conversion to is in progress
Conversion to is failed